BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32934818)

  • 1. Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings.
    Ishida H; Iguchi A; Aoe M; Nishiuchi R; Matsubara T; Keino D; Sanada M; Shimada A
    Biomed Rep; 2020 Nov; 13(5):46. PubMed ID: 32934818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization of mutational pattern of patients with core-binding factor acute myeloid leukemia].
    He J; Chao H; Zhou M; Lu X; Chen T; Yang J; Jiang N; Zhang R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):657-661. PubMed ID: 31302905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid Leukemia.
    Krizsán S; Péterffy B; Egyed B; Nagy T; Sebestyén E; Hegyi LL; Jakab Z; Erdélyi DJ; Müller J; Péter G; Csanádi K; Kállay K; Kriván G; Barna G; Bedics G; Haltrich I; Ottóffy G; Csernus K; Vojcek Á; Tiszlavicz LG; Gábor KM; Kelemen Á; Hauser P; Gaál Z; Szegedi I; Ujfalusi A; Kajtár B; Kiss C; Matolcsy A; Tímár B; Kovács G; Alpár D; Bödör C
    J Mol Diagn; 2023 Aug; 25(8):555-568. PubMed ID: 37088137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of Genomic Landscape in Patients with Acute Myeloid Leukemia].
    Wang SM; Zheng HJ; Tian Y; Zhang JM; Yao JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):797-801. PubMed ID: 32552938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coexisting mutations in NPM1-mutated elderly adults with acute myeloid leukemia].
    Qin W; Chao HY; Cai XH; Lu XZ; Liu J; Wu P; Chen MY
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3152-3157. PubMed ID: 31694106
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification.
    de Noronha TR; Mitne-Neto M; Chauffaille ML
    J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
    Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
    [No Abstract]   [Full Text] [Related]  

  • 10. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.
    Cloos J; Goemans BF; Hess CJ; van Oostveen JW; Waisfisz Q; Corthals S; de Lange D; Boeckx N; Hählen K; Reinhardt D; Creutzig U; Schuurhuis GJ; Zwaan ChM; Kaspers GJ
    Leukemia; 2006 Jul; 20(7):1217-20. PubMed ID: 16642044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Characterization of Pediatric Acute Myeloid Leukemia: Results of a Multicentric Study in Brazil.
    Andrade FG; Noronha EP; Brisson GD; Dos Santos Vicente Bueno F; Cezar IS; Terra-Granado E; Thuler LCS; Pombo-de-Oliveira MS;
    Arch Med Res; 2016 Nov; 47(8):656-667. PubMed ID: 28476193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
    Duncavage EJ; Tandon B
    Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
    Sargas C; Ayala R; Larráyoz MJ; Chillón MC; Carrillo-Cruz E; Bilbao-Sieyro C; Prados de la Torre E; Martínez-Cuadrón D; Rodríguez-Veiga R; Boluda B; Gil C; Bernal T; Bergua JM; Algarra L; Tormo M; Martínez-Sánchez P; Soria E; Serrano J; Alonso-Domínguez JM; García-Boyero R; Amigo ML; Herrera-Puente P; Sayas MJ; Lavilla-Rubira E; Martínez-López J; Calasanz MJ; García-Sanz R; Pérez-Simón JA; Gómez-Casares MT; Sánchez-García J; Barragán E; Montesinos P; On Behalf Of Pethema Group
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia.
    Kaburagi T; Yamato G; Shiba N; Yoshida K; Hara Y; Tabuchi K; Shiraishi Y; Ohki K; Sotomatsu M; Arakawa H; Matsuo H; Shimada A; Taki T; Kiyokawa N; Tomizawa D; Horibe K; Miyano S; Taga T; Adachi S; Ogawa S; Hayashi Y
    Haematologica; 2022 Mar; 107(3):583-592. PubMed ID: 33730843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin.
    Ottone T; Zaza S; Divona M; Hasan SK; Lavorgna S; Laterza S; Cicconi L; Panetta P; Di Giandomenico J; Cittadini M; Ciardi C; Montefusco E; Franchi A; Annino L; Venditti A; Amadori S; Lo-Coco F
    Br J Haematol; 2013 May; 161(4):533-40. PubMed ID: 23480665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
    Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
    Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
    Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
    Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
    Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
    Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.
    Goemans BF; Zwaan CM; Miller M; Zimmermann M; Harlow A; Meshinchi S; Loonen AH; Hählen K; Reinhardt D; Creutzig U; Kaspers GJ; Heinrich MC
    Leukemia; 2005 Sep; 19(9):1536-42. PubMed ID: 16015387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG).
    Salmoiraghi S; Cavagna R; Zanghì P; Pavoni C; Michelato A; Buklijas K; Elidi L; Intermesoli T; Lussana F; Oldani E; Caprioli C; Stefanoni P; Gianfaldoni G; Audisio E; Terruzzi E; De Paoli L; Borlenghi E; Cavattoni I; Mattei D; Scattolin A; Tajana M; Ciceri F; Todisco E; Campiotti L; Corradini P; Fracchiolla N; Bassan R; Rambaldi A; Spinelli O
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32796597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.